Home Cart 0 Sign in  

[ CAS No. 522-48-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 522-48-5
Chemical Structure| 522-48-5
Structure of 522-48-5 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 522-48-5 ]

Related Doc. of [ 522-48-5 ]

Alternatived Products of [ 522-48-5 ]

Product Details of [ 522-48-5 ]

CAS No. :522-48-5 MDL No. :MFCD00058029
Formula : C13H17ClN2 Boiling Point : -
Linear Structure Formula :- InChI Key :BJORNXNYWNIWEY-UHFFFAOYSA-N
M.W : 236.74 Pubchem ID :10648
Synonyms :
Tetryzoline hydrochloride;Tetrahydrozoline (hydrochloride);Tetryzoline;Tetryzoline HCl;Tetrahydrozoline hydrochloride
Chemical Name :2-(1,2,3,4-Tetrahydronaphthalen-1-yl)-4,5-dihydro-1H-imidazole hydrochloride

Calculated chemistry of [ 522-48-5 ]

Physicochemical Properties

Num. heavy atoms : 16
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.46
Num. rotatable bonds : 1
Num. H-bond acceptors : 1.0
Num. H-bond donors : 1.0
Molar Refractivity : 76.87
TPSA : 24.39 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : Yes
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.91 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.0
Log Po/w (XLOGP3) : 2.59
Log Po/w (WLOGP) : 2.15
Log Po/w (MLOGP) : 3.0
Log Po/w (SILICOS-IT) : 3.6
Consensus Log Po/w : 2.27

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.15
Solubility : 0.167 mg/ml ; 0.000706 mol/l
Class : Soluble
Log S (Ali) : -2.75
Solubility : 0.42 mg/ml ; 0.00177 mol/l
Class : Soluble
Log S (SILICOS-IT) : -4.2
Solubility : 0.0151 mg/ml ; 0.0000638 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 3.08

Safety of [ 522-48-5 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 522-48-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 522-48-5 ]

[ 522-48-5 ] Synthesis Path-Downstream   1~5

YieldReaction ConditionsOperation in experiment
EXAMPLE 5 Preparation of a collyrium containing indomethacin and tetrahydrozoline hydrochloride (Composition 5)
Example 5 Preparation of a collyrium containing indomethacin and tetrahydrozoline hydrochloride (Composition 5)
YieldReaction ConditionsOperation in experiment
EXAMPLE 4 Preparation of a collyrium containing sodium diclofenac and tetrahydrozoline hydrochloride (Composition 4)
Example 4 Preparation of a collyrium containing sodium diclofenac and tetrahydrozoline-hydrochloride (Composition 4)
YieldReaction ConditionsOperation in experiment
EXAMPLE 6 Preparation of a collyrium containing flurbiprofen and tetrahydrozoline hydrochloride (Composition 6)
Example 6 Preparation of a collyrium containing flurbiprofen and tetrahydrozoline hydrochloride (Composition 6)
YieldReaction ConditionsOperation in experiment
Example 2 Eye drops containing Azelastine HCl (0.05%) and Tetryzoline HCl (0.05%) Example 3 Nasal spray or nasal drops See example 1 but with 0.1% Xylomethazoline HCl instead of 0.05% Oxymethazoline HCl
YieldReaction ConditionsOperation in experiment
An aqueous solution of 0.5% dapiprazole HCl and 0.1% tetrahydrozoline HCl w/v was prepared in an isotonic saline solution.
Same Skeleton Products
Historical Records